Additional Benefit Seen for Colonoscopy Versus Sigmoidoscopy
By Elana Gotkine HealthDay Reporter
TUESDAY, March 5, 2024 -- There may be a limited additional colorectal cancer (CRC) screening benefit for colonoscopy compared with sigmoidoscopy, according to a study published online Feb. 29 in JAMA Network Open.
Frederik E. Juul, M.D., Ph.D., from the University of Oslo in Norway, and colleagues estimated the additional screening benefit of colonoscopy compared with sigmoidoscopy in a comparative effectiveness simulation study using pooled data for 358,204 men and women. Participants were randomly assigned to sigmoidoscopy screening or usual care.
The researchers found that colonoscopy prevented an estimated 50 CRC cases per 100,000 person-years, corresponding to a 30 percent incidence reduction, and prevented an estimated 15 CRC deaths per 100,000 person-years, corresponding to a 32 percent mortality reduction (rate ratios, 0.70 and 0.68, respectively). Compared with sigmoidoscopy, the additional benefit of colonoscopy screening was 12 fewer CRC cases and four fewer CRC deaths per 100,000 person-years, corresponding to reductions of 6.9 and 7.6 percentage points for CRC incidence and mortality. To prevent one CRC case and one CRC death, the number needed to switch from sigmoidoscopy to colonoscopy screening was 560 and 1,611, respectively.
"Compared with sigmoidoscopy screening, colonoscopy screening provided 6.9 percentage points additional reductions in CRC incidence and 7.6 percentage points additional reductions in CRC mortality, which means that the additional preventive effect of colonoscopy compared with sigmoidoscopy was less than what was achieved by introducing sigmoidoscopy screening where no screening existed," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
MONDAY, July 1, 2024 -- Income and area-level disadvantage are the largest contributors to racial differences in financial hardship among older U.S. adults with cancer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.